US 7,807,155 · Application 11/658,344
US Patent 7,807,155 — assignment history and current owner
Il-17 Antagonistic Antibodies
Who owns US Patent 7,807,155?
US7807155 ("Il-17 Antagonistic Antibodies") — current assignee: NOVARTIS PHARMA AG. Status: Active, estimated expiration July 26, 2027. 2 recorded USPTO assignments.
Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 7,807,155 is NOVARTIS PHARMA AG. Based on the most recent ownership transfer record (recorded 2026-06-11).
- Patent title
- Il-17 Antagonistic Antibodies
- Application number
- 11/658,344
- Apparent operating assignee
- NOVARTIS PHARMA AG
- Patent status
- Active, estimated expiration July 26, 2027
- Recorded assignments
- 2
Recorded assignment history
| Executed | Recorded | Conveyance | Assignor(s) | Assignee(s) | Reel/frame |
|---|---|---|---|---|---|
| Jan 8, 2007 | Feb 9, 2010 | Ownership Transfer | DI PADOVA, FRANCO E; GRAMM, HERMANN; HOFSTETTER, HANS; JESCHKE, MARGIT; RONDEAU, JEAN-MICHEL; VAN DEN BERG, WIM | NOVARTIS AG | 23916/165 |
| Dec 19, 2025 | Jun 11, 2026 | Ownership Transfer | NOVARTIS AG | NOVARTIS PHARMA AG | 75712/291 |
Scrolls sideways on narrow screens
Chain of title
In 2010, DI PADOVA, FRANCO E; GRAMM, HERMANN (+4 more) assigned the patent to NOVARTIS AG. The most recent ownership transfer, recorded in 2026, lists NOVARTIS PHARMA AG as assignee.
Apparent recorded rights summary — disclaimer
This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.
The prosecution record for your AI
Application 11/658,344 · US 7,807,155
Ownership settled? Give your AI the file.
The recorded chain of title is one part of the record. PatentReply compiles the rest of US 7,807,155, from the claims as filed to the last action, for Claude, ChatGPT, Cursor, or another supported AI workspace.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.